Autonomix Medical, Inc. (AMIX)

Autonomix Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	7.48	9.14	8.61	0.87	2.04
Cash & Short-Term Investments	7.48	9.14	8.61	0.87	2.04
Cash Growth	45.04%	6.13%	895.14%	-57.68%	-
Other Current Assets	0.42	0.47	0.78	-	0.01
Total Current Assets	7.89	9.61	9.39	0.87	2.05
Property, Plant & Equipment	0.02	0.02	0.02	-	-
Long-Term Deferred Charges	0.02	0.18	-	-	-
Total Assets	7.93	9.81	9.41	0.87	2.05
Accounts Payable	0.84	0.68	0.49	0.17	0.09
Accrued Expenses	0.65	1.03	0.29	0.05	0
Total Current Liabilities	1.49	1.71	0.78	0.22	0.09
Long-Term Debt	-	-	1	-	-
Total Liabilities	1.49	1.71	1.78	0.22	0.09
Common Stock	0.01	0	0	0.01	0.01
Additional Paid-In Capital	67.61	58.48	46.6	24.18	23.5
Retained Earnings	-61.17	-50.38	-38.97	-23.54	-21.55
Shareholders' Equity	6.45	8.1	7.63	0.64	1.96
Total Liabilities & Equity	7.93	9.81	9.41	0.87	2.05
Total Debt	-	-	1	-	-
Net Cash (Debt)	7.48	9.14	7.61	0.87	2.04
Net Cash Growth	83.75%	20.12%	779.31%	-57.68%	-
Net Cash Per Share	2.28	5.17	7.31	1.44	19.73
Filing Date Shares Outstanding	6.89	2.78	0.94	0.89	0.1
Total Common Shares Outstanding	6.19	2.5	0.94	0.62	0.1
Working Capital	6.41	7.9	8.61	0.64	1.96
Book Value Per Share	1.04	3.24	8.10	1.04	18.91
Tangible Book Value	6.45	8.1	7.63	0.64	1.96
Tangible Book Value Per Share	1.04	3.24	8.10	1.04	18.91

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q